RETaliation - tackling rare resistance alterations to osimertinib

Matthew G. Krebs, Sanjay Popat

Research output: Contribution to journal › Commentary/debate › peer-review

Fingerprint

Dive into the research topics of 'RETaliation - tackling rare resistance alterations to osimertinib'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science